Differences

This shows you the differences between two versions of the page.

--- mdma_ecstasy [2026/02/28 09:40] – created susannahikf
+++ mdma_ecstasy [2026/08/21 22:34] (current) – removed - external edit (Unknown date) 127.0.0.1
@@ Line 1: / Line 1: @@
-In 2023, 39 % of the MDMA tablets tested by drug checking organisations submitting data to the TEDI network contained between 100 and 149.0 milligrams of MDMA (35 % in the same period in 2022), and 26 % contained between 150 and 199.9 milligrams (29 % in 2022
-Where prevalence is higher, it may suggest that MDMA is no longer a niche or subcultural drug limited to dance clubs and parties in those markets. According to survey data, the two largest MDMA consumer markets per capita in the European Union are the Netherlands and Ireland, with 6 % or more mdma for sale online people aged 15 to 34 reporting to have consumed MDMA in the last year. Some of the high-strength ecstasy tablets are scored to allow consumers to divide them into smaller portions.
-It’s important to be careful when taking any type of drug. This makes it hard to know what reactions to expect after taking MDMA or if negative side effects will be experienced. RAND is a research organization that develops solutions to public policy challenges to help make communities throughout the world safer and more secure, healthier and more prosperous. In essence, cryptomarkets have grown at a fairly decent rate since 2013, but their global impact could be overstated — for now. The specialization also reflects the interconnection of physical and virtual drug distribution channel
-Surrey Young People’s Substance Use Service
-Since most users take this drug only occasionally, dependence is not very prominent. Although some users become dependent, very few cases of MDMA-specific dependence have been reported in the literature. That said, with repeated use, it becomes difficult, if not impossible for users to experience the same effects they did when they first started. The significant mdma for sale online increase in serotonin and dopamine during MDMA use can result in users seeking these feelings repeatedly, leading to habitual use and eventually, dependency. The addiction risk ties back to its effects on neurotransmitters. They can lead to extended wakefulness and increased physical activity, which can strain the user’s cardiovascular system and overall physical health.
-Together, these two data sources suggests that the large majority of MDMA users buy the drug themselves, and that a smaller proportion obtains it for free, despite marked differences among EU countries. Despite their image as risk-taking hedonists, people who use drugs recreationally do seek out and share harm reduction strategies, often alongside ‘pleasure maximisation’ strategies (the latter often requiring considerable knowledge of drug research, policy and practice). Given the right information and opportunities, most people who use drugs will make rational risk-management decisions when they do so. Given the option, it is clear that people who use MDMA and other drugs will embrace harm reduction approaches, and support their development. Harm reduction is not a principle that policy makers will need to force upon people who use MDMA or other drugs in nightlife and party settings. Significant numbers of people not only like MDMA’s effects and are willing to take known risks (health and legal) to enjoy them, but they seem to prefer it to most available substitute
-It is clear that MDMA has a considerably more resilient popularity than any other amphetamine-type stimulant or synthetic drug that has entered the market in recent history. As so often, enforcement interventions have failed to prevent rising use, or prevent supply in the longer term, instead only serving to temporarily displace using behaviours and mutate the market in ways that increased health harms. Of those who reported obtaining MDMA in the 2019 Global Drug Survey, 67% reported having obtained it through the darknet — higher than mdma for sale online for any other dru
-Importantly, reported use of the drug declined temporarily during periods of social distancing during the early phases of the COVID-19 pandemic, coinciding with the closure of nightlife and the cancellation of events where MDMA is typically consumed. Of the 13 EU countries that undertook surveys since 2021 and provided confidence intervals, four reported higher estimates than their previous comparable survey, nine reported stable estimates and one reported a decrease. General population surveys in many countries showed that MDMA prevalence was declining from peak levels attained in the early to mid-2000s. Data on prevalence of use provide an indication of the structure, location and approximate size of retail MDMA markets in the European Unio
-The 225 vendors operating from the Netherlands generated $1.1 million in drug revenues per month and ranked fifth, after the US, UK, Australia, and Germany. The Netherlands is the main producer of MDMA, ecstasy, and herbal cannabis and a key distribution hub for cannabis [[https://royalmedspharma.com/mdma-legality-standing-by-country/|mdma for sale online]] resin and cocaine in Europe. The Netherlands seems to be an anomaly when it comes to domestic drug sales. With American buyers able to source cannabis, for example, from Colorado and Washington, where the drug has been legalized, why risk purchase from abroad? It was difficult to estimate the share of drug shipping routes precisely, as incomplete or unknown routes account for more than one-third of all drug revenues. While it is difficult to derive information about buyer locations, sellers usually indicate the countries or continents they are willing to ship their products to.
-Reporting countries
-According to survey data, the two largest MDMA consumer markets per capita in the European Union are the Netherlands and Ireland, with 6 % or more people aged 15 to 34 reporting to have consumed MDMA in the last year. Some of the high-strength ecstasy tablets are scored to allow consumers to divide them into smaller portions. These identifications of high-strength ecstasy tablets prompted harm reduction organisations to issue alerts. In December 2023, beige-golden ecstasy pills with an Audi-logo containing over 300 milligrams of MDMA (between 316 and 324 milligrams) were submitted to drug testing in the Netherlands (DIMS, 2023). However, this trend appears to be changing, as ecstasy tablets have tended to contain less MDMA since 201